V-Ensure Pharma Technologies Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 4.11 Cr
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 45.00 Cr
- Satisfied Charges ₹ 20.70 Cr
- Revenue Growth -10.98%
- Profit Growth -59.94%
- Ebitda -22.50%
- Net Worth 340.63%
- Total Assets 182.79%
About V-Ensure Pharma Technologies
V-Ensure Pharma Technologies Private Limited (VPTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 July 2010 and has a history of 14 years and six months. Its registered office is in Navi Mumbai, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.11 Cr.
The company currently has active open charges totaling ₹45.00 Cr. The company has closed loans amounting to ₹20.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at V-Ensure Pharma Technologies Private Limited India are Ashwin Trinidad as CFO and Srishti Tiwari as Company Secretary. Sathyanarayana Vemula, Mousumi Vemula, and Gaurav Sharma serve as directors at the Company.
Company Details
- Location Navi Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74990MH2010PTC205969
- Company No.
205969
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does V-Ensure Pharma Technologies Private Limited offer?
V-Ensure Pharma Technologies Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at V-Ensure Pharma Technologies?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwin Trinidad  | CFO | 26-Jun-2024 | Current |
| Srishti Tiwari | Company Secretary | 21-Dec-2022 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sathyanarayana Vemula | Director | 14-Mar-2020 | Current |
| Mousumi Vemula | Director | 26-Jul-2010 | Current |
| Gaurav Sharma | Director | 02-Feb-2022 | Current |
Financial Performance of V-Ensure Pharma Technologies.
V-Ensure Pharma Technologies Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.98% decrease. The company also saw a substantial fall in profitability, with a 59.94% decrease in profit. The company's net worth Soared by an impressive increase of 340.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of V-Ensure Pharma Technologies?
In 2022, V-Ensure Pharma Technologies had a promoter holding of 94.84% and a public holding of 5.15%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Canpac Trends Private LimitedGaurav Sharma is a mutual person
Nusummit Technologies Private LimitedGaurav Sharma is a mutual person
Medi Assist Healthcare Services LimitedGaurav Sharma is a mutual person
Safari Industries (India) LimitedGaurav Sharma is a mutual person
Investcorp India Asset Managers Private LimitedGaurav Sharma is a mutual person
Wingreens Farms Private LimitedGaurav Sharma is a mutual person
Charges (Loans)
₹45.00 Cr
₹20.70 Cr
Charges Breakdown by Lending Institutions
- Standard Chartered Bank : 28.00 Cr
- Axis Bank Limited : 17.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2021 | Axis Bank Limited | ₹17.00 Cr | Open |
| 16 Sep 2020 | Standard Chartered Bank | ₹28.00 Cr | Open |
| 26 Oct 2017 | Axis Bank Limited | ₹5.00 Cr | Satisfied |
| 19 Jul 2017 | Axis Bank Limited | ₹5.00 Cr | Satisfied |
| 28 Jun 2017 | Axis Bank Limited | ₹2.00 Cr | Satisfied |
How Many Employees Work at V-Ensure Pharma Technologies?
Unlock and access historical data on people associated with V-Ensure Pharma Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of V-Ensure Pharma Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped V-Ensure Pharma Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
